Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM0ZDJ5)

Drug Name

Anti-EGFL7 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 1	[1]

Cross-matching ID

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Epidermal growth factor-like protein 7 (EGFL7)	TT7WD0H	EGFL7_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Epidermal growth factor-like protein 7 (EGFL7)	DTT	EGFL7	6.632	5.514	4.907	6.053

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Non-small-cell lung cancer

ICD Disease Classification

2C25.Y

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Epidermal growth factor-like protein 7 (EGFL7)	DTT	EGFL7	2.56E-01	0.07	0.33

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Clinical pipeline report, company report or official report of Genentech (2011).
2	Clinical pipeline report, company report or official report of Genentech (2009).